MarketInOut Stock Screener Log In | Sign Up
 

Benitec Biopharma Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/16/2026 16:00
Benitec Biopharma Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization289.18 mln
Float33.99 mln
Earnings Date11/16/2026

Piotroski F-Score

4 / 9
Borderline

Relative Strength

26 / 100
Underperforming

Debt / Equity

0.00
Debt-free

ROE

-30.83
Deeply negative

ROA

-30.13
Deeply negative

Business Description

Benitec Biopharma is a clinical-stage company working to create new treatments based on genetic medicine. Using its proprietary platform, the company develops therapies that can switch off harmful genes while simultaneously introducing healthy replacement genes ? all through a single treatment. Its lead program targets oculopharyngeal muscular dystrophy, a condition that causes progressive difficulty swallowing. The company operates from its headquarters in Hayward, California.

Key Fundamentals

EPS-0.94
ROE-30.83
ROIC-2,184
ROA-30.13
Interest Cover21.32
EBITDA, mln-45.06
EV / EBITDA-3.70
EV / EBIT-3.66

Quote Details

Last 8.11
Change -0.35 (-4.14%)
Open 8.47
Volume 158,557
Turnover 1,285,897
Average Volume 209,279

Financial Ratios

Leverage Ratio1.03
Current Ratio34.00
Price / Book1.93
Price / Tangible Book1.93
Debt / Equity0.00

Financial Strength

Piotroski F-Score 4 / 9
Short Ratio13.26
Short % of Float10.23

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -8.57% 24 / 100   
1 Month -28.61% 11 / 100   
2 Months -37.57% 13 / 100   
6 Months -42.4% 15 / 100   
1 Year -48.99% 19 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us